tom beer, md, shares impressions of the titan study invesigating 1st line therapy in mcrpc patients
Published 4 years ago • 28 plays • Length 0:57
Download video MP4
Download video MP3
Similar videos
-
0:42
tom beer, md, on impressions of the card study investigating cabazitaxel in mcrpc patients
-
2:11
tomasz m. beer md, facp, discusses outcomes from the titan study in mcspc
-
0:47
tom beer, md on the data presented at asco gu20 investigating atezolizumab and cabozantinib in mcrpc
-
3:16
counseling patients with mcrpc
-
0:44
tom beer, md, explains whether pfs2 is a legitimate endpoint in prostate cancer clinical trials
-
11:19
radiation therapy for prostate cancer in prostate bed and lymph nodes
-
35:22
advanced prostate cancer imaging
-
8:56
abiraterone in metastatic prostate cancer
-
0:47
tanya dorff, md, on impressions of the card study investigating the role of cabazitaxel in mcrpc
-
1:59
fred saad, md, shares impressions of the card study investigating cabazitaxel in nmcrpc patients
-
0:58
andrew armstrong, md, on impressions of the card study investigating cabazitaxel in mcrpc patients
-
10:26
expert comment: antiandrogens in nonmetastatic crpc | tomasz beer
-
3:06
titan trial
-
2:19
tomasz m. beer md, facp, on the efficacy of abiraterone enzalutamide in mcrpc
-
1:01
rana mckay, md, on impressions of the card study investigating the role of cabazitaxel in mcrpc
-
0:42
oliver sartor, md, on impressions of the card study investigating the role of cabazitaxel in mcrpc
-
1:34
dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer
-
41:52
psma therapeutics with dr. tomasz beer - zero prostate cancer summit 2022
-
1:32
anis hamid, md, on impressions of the card study investigating the role of cabazitaxel in mcrpc
-
2:04
dr. beer on the design and results of the prevail trial
-
1:41
faces of prostate cancer: dr. tomasz beer
-
6:41
esmo expert report on combination therapy in advanced prostate cancer @ asco gu 2022
Clip.africa.com - Privacy-policy